Interpersonal psychotherapy for depression and posttraumatic stress disorder among HIV-positive women in Kisumu, Kenya: study protocol for a randomized controlled trial

Chinwe Onu, Linnet Ongeri, Elizabeth Bukusi, Craig R Cohen, Thomas C Neylan, Patrick Oyaro, Grace Rota, Faith Otewa, Kevin L Delucchi, Susan M Meffert, Chinwe Onu, Linnet Ongeri, Elizabeth Bukusi, Craig R Cohen, Thomas C Neylan, Patrick Oyaro, Grace Rota, Faith Otewa, Kevin L Delucchi, Susan M Meffert

Abstract

Background: Mental disorders are the leading global cause of years lived with disability; the majority of this burden exists in low and middle income countries (LMICs). Over half of mental illness is attributable to depression and anxiety disorders, both of which have known treatments. While the scarcity of mental health care providers is recognized as a major contributor to the magnitude of untreated disorders in LMICs, studies in LMICs find that evidence-based treatments for depression and anxiety disorders, such as brief, structured psychotherapies, are feasible, acceptable and have strong efficacy when delivered by local non-specialist personnel. However, most mental health treatment studies using non-specialist providers in LMICs deploy traditional efficacy designs (T1) without the benefit of integrated mental health treatment models shown to succeed over vertical interventions or methods derived from new implementation science to speed policy change. Here, we describe an effectiveness-implementation hybrid study that evaluates non-specialist delivery of mental health treatment within an HIV clinic for HIV-positive (HIV+) women affected by gender- based violence (GBV) (HIV+ GBV+) in the Nyanza region of Kenya.

Methods/design: In this effectiveness-implementation hybrid type I design, 200 HIV+ women with major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) who are receiving care at a Family AIDS Care Education and Services (FACES)-supported clinic in Kisumu, Kenya will be randomized to: (1) interpersonal psychotherapy (IPT) + treatment as usual (TAU) or (2) TAU, both delivered within the HIV clinic. IPT will consist of 12 weekly 60-minute individual IPT sessions, delivered by non-specialists trained to provide IPT. Primary effectiveness outcomes will include MDD and PTSD diagnosis on the Mini International Diagnostic Interview (MINI). Primary implementation outcomes will include treatment cost-benefit, acceptability, appropriateness, feasibility and fidelity of the IPT delivery within an HIV clinic.

Discussion: This trial leverages newly defined effectiveness-implementation hybrid designs to gather data on mental health treatment implementation within an HIV care clinic, while testing the effectiveness of an evidence-based treatment for use with a large underserved population (HIV+ GBV+ women) in Kenya.

Clinical trials identifier: NCT02320799, registered on 9 September 2014.

References

    1. World Health Organization. WHO | mhGAP Mental Health Gap Action Programme [Internet]. World Health Organization. 2008. Available: . Accessed 15 Dec 2015.
    1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–86. doi: 10.1016/S0140-6736(13)61611-6.
    1. van Ginneken N, Tharyan P, Lewin S, Rao GN, Meera S, Pian J, et al. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries. Cochrane Database Syst Rev. 2013;11
    1. Global Burden of Disease Study 2013 Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;15:60692–4.
    1. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26. doi: 10.1097/MLR.0b013e3182408812.
    1. Campbell JC, Baty ML, Ghandour RM, Stockman JK, Francisco L, Wagman J. The intersection of intimate partner violence against women and HIV/AIDS: a review. Int J Inj Contr Saf Promot. 2008;15:221–31. doi: 10.1080/17457300802423224.
    1. Cohen M, Deamant C, Barkan S, Richardson J, Young M, Holman S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health. 2000;90:560–5. doi: 10.2105/AJPH.90.4.560.
    1. Rees S, Silove D, Chey T, Ivancic L, Steel Z, Creamer M, et al. Lifetime prevalence of gender-based violence in women and the relationship with mental disorders and psychosocial function. JAMA. 2011;306:513–21.
    1. Rees S, Steel Z, Creamer M, Teesson M, Bryant R, McFarlane AC, et al. Onset of common mental disorders and suicidal behavior following women’s first exposure to gender based violence: a retrospective, population-based study. BMC Psychiatry. 2014;14:312.
    1. Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11:291–307. doi: 10.1007/s11904-014-0220-1.
    1. Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10:253–61. doi: 10.1007/s10461-006-9069-7.
    1. Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med Publ Soc Behav Med. 2014;47:259–69. doi: 10.1007/s12160-013-9559-6.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Global Report 2012 [Internet]. Joint United Nations Programme on HIV/AIDS. 2012. Available: . Accessed 15 Dec 2015.
    1. Garcia-Moreno C, Jansen HAFM, Ellsberg M, Heise L, Watts CH. Prevalence of intimate partner violence: findings from the WHO multi-country study on women’s health and domestic violence. Lancet. 2006;368:1260–9. doi: 10.1016/S0140-6736(06)69523-8.
    1. Kenya National AIDS and STI Control Program (NASCOP), Kenya National AIDS Control Council (NACC), Kenya National Bureau of Statistics (KNBS), National Public Health Laboratory Services (NPHLS), Kenya Medical Research Institute (KEMRI), and the National Coordinating Agency for Population and Development (NCAPD). Kenya AIDS Indicator Survey 2007; 2007.
    1. Kenya National Bureau of Statistics (KNBS), ICF Macro . Kenya Demographic and Health Survey 2008–09. Calverton: KNBS and ICF Macro; 2010.
    1. Zunner B, Dworkin SL, Neylan TC, Bukusi EA, Oyaro P, Cohen CR, et al. HIV, violence and women: unmet mental health care needs. J Affect Disord. 2015;174:619–26. doi: 10.1016/j.jad.2014.12.017.
    1. Markowitz JC, Weissman MM. Interpersonal psychotherapy: principles and applications. World Psychiatry. 2004;3:136–9.
    1. Markowitz JC, Klerman GL, Clougherty KF, Spielman LA, Jacobsberg LB, Fishman B, et al. Individual psychotherapies for depressed HIV-positive patients. Am J Psychiatry. 1995;152:1504–9. doi: 10.1176/ajp.152.10.1504.
    1. Markowitz JC, Petkova E, Neria Y, Van Meter PE, Zhao Y, Hembree E, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015;172:430–40. doi: 10.1176/appi.ajp.2014.14070908.
    1. ISIPT – International Society for Interpersonal Psychotherapy [Internet]. Available: . Accessed 25 Jan 2015.
    1. Sheehan DV, Lecrubier Y. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
    1. Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17:268–74. doi: 10.1111/j.1365-2753.2010.01434.x.
    1. van Ommeren M, Saxena S, Saraceno B. Mental and social health during and after acute emergencies: emerging consensus? Bull World Health Organ. 2005;83:71–5.
    1. Misch DA. Basic strategies of dynamic supportive therapy. J Psychother Pract Res. 2000;9:173–89.
    1. Jiang RF, Tong H, Delucchi KL, Neylan TC, Shi Q, Meffert SM. Interpersonal psychotherapy versus treatment as usual for PTSD and depression among Sichuan earthquake survivors: a randomized clinical trial. Confl Health. 2014;8:14. doi: 10.1186/1752-1505-8-14.
    1. Meffert SM, Abdo AO, Alla OAA, Elmakki YOM, Omer AA, Yousif S, et al. Sudanese refugees in Cairo, Egypt: a randomized controlled trial of interpersonal psychotherapy for trauma, depression and interpersonal violence. Psychol Trauma Theory Res Pract Policy. 2009;24:1835–48.
    1. Novins D, Green A, Legha R, Aarons G. Dissemination and implementation of evidence-based practices for child and adolescent mental health: a systematic review. J Am Acad Child Adolesc Psychiatry. 2013;52:1009–25. doi: 10.1016/j.jaac.2013.07.012.
    1. Reynolds M, Mezey G, Chapman M, Wheeler M, Drummond C, Baldacchino A. Co-morbid post-traumatic stress disorder in a substance misusing clinical population. Drug Alcohol Depend. 2005;77:251–8. doi: 10.1016/j.drugalcdep.2004.08.017.
    1. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG, World Health Organization . AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care. 2. Geneva: World Health Organization; 2001.
    1. Skinner H. The Drug Abuse Screening Test. Addict Behav. 1982;7:363–71. doi: 10.1016/0306-4603(82)90005-3.
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71. doi: 10.1001/archpsyc.1961.01710120031004.
    1. Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The Revised Conflict Tactics Scales (CTS2): development and preliminary psychometric data. J Fam Issues. 1996;17:283–316. doi: 10.1177/019251396017003001.
    1. Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Paper presented at the International Society for Traumatic Stress Studies, San Antonio, TX; 1993.
    1. Weissman MM, Prusoff BA, Thompson WD, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 1978;166:317–26. doi: 10.1097/00005053-197805000-00002.
    1. Carlson EB, Smith SR, Palmieri PA, Dalenberg C, Ruzek JI, Kimerling R, et al. Development and validation of a brief self-report measure of trauma exposure: the Trauma History Screen. Psychol Assess. 2011;23:463–77. doi: 10.1037/a0022294.
    1. World Health Organization. The World Health Organization Quality of Life (WHOQOL)-BREF. Geneva, Switzerland: World Health Organization; 2004.
    1. Ustun T, Kostanjsek N, Chatterji S, Rehm J, editors. World Health Organization Disability Assessment Schedule: WHODAS 2.0. Geneva, Switzerland: World Health Organization; 2010.
    1. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, et al. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012;7 doi: 10.1371/journal.pone.0032898.
    1. Meyer A-CL, Boscardin WJ, Kwasa JK, Price RW. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 2013;41:208–16. doi: 10.1159/000354629.
    1. Meyer A-C. Neurology and the global HIV epidemic. Semin Neurol. 2014;34:70–7. doi: 10.1055/s-0034-1372344.
    1. D’Elia L, Satz P, Uchiyama C, White T. Color Trails Test professional manual. Lutz: Psychological Assessment Resources, Inc.; 1996.
    1. Strauss E, Sherman EM, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3 edition. Oxford, New York: Oxford University Press; 2006.
    1. Bornstein R. Consistency of intermanual discrepancies in normal and unilateral brain lesion patients. J Consult Clin Psychol. 1986;54:719–723.
    1. Weschler D. Weschler Adult Intelligence Scale – Third Edition (WAIS III). Geneva, Switzerland: The Psychological Corporation: A Harcourt Assessment Company; 1997.
    1. Benedict R. Brief Visuospatial Memory Test-Revised. Lutz: Psychological Assessment Resources, Inc.; 1997.
    1. Lezak MD. Neuropsychological assessment. Oxford, New York: Oxford University Press; 2012.
    1. Satz P, Chervinsky A, D’Elia L. The WHO/UCLA Auditory Verbal Learning Test (AVLT) 1993.
    1. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74–9. doi: 10.1310/JFXH-G3X2-EYM6-D6UG.
    1. McAllister N, Elshtewi M, Badr L, Russell IF, Lindow SW. Pregnancy outcomes in women with severe needle phobia. Eur J Obstet Gynecol Reprod Biol. 2012;162:149–52. doi: 10.1016/j.ejogrb.2012.02.019.
    1. Patel VH, Kirkwood BR, Pednekar S, Araya R, King M, Chisholm D, et al. Improving the outcomes of primary care attenders with common mental disorders in developing countries: a cluster randomized controlled trial of a collaborative stepped care intervention in Goa, India. Trials. 2008;9:4. doi: 10.1186/1745-6215-9-4.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir